Memory and attention performance in psychiatric patients: Lack of correspondence between clinician-rated and patient-rated functioning with neuropsychological test results

Journal of the International Neuropsychological Society

Volumn 10, Issue 4, 2004, Pages 623-633

  Moritz, Steffen ^a   Ferahli, Sabine ^a   Naber, Dieter ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Attention; Clinical judgement; Memory; Neuropsychology; Psychometric tests; Self report

Indexed keywords

ADULT; AGED; ARTICLE; ATTENTION; COGNITION; CONTROLLED STUDY; DENIAL; DEPRESSION; DISEASE ASSOCIATION; FEMALE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MEMORY; MENTAL FUNCTION; MENTAL PATIENT; MENTAL PERFORMANCE; NERVOUS SYSTEM PARAMETERS; NEUROPSYCHOLOGICAL TEST; PHYSICIAN; PRIORITY JOURNAL; PSYCHOMETRY; RATING SCALE; RELIABILITY; SCHIZOPHRENIA; SCORING SYSTEM; SELF REPORT; SENSITIVITY ANALYSIS; SYMPTOMATOLOGY; VALIDATION PROCESS;

ADULT; ATTENTION; COGNITION DISORDERS; FEMALE; HUMANS; MALE; MEMORY; MENTAL DISORDERS; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; PSYCHOMOTOR PERFORMANCE; REPRODUCIBILITY OF RESULTS; SELF ASSESSMENT (PSYCHOLOGY); VERBAL LEARNING;

EID: 4043135826     PISSN: 13556177     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1355617704104153     Document Type: Article

References (52)

1. Antikainen, R., Hanninen, T., Honkalampi, K., Hintikka, J., Koivumaa-Honkanen, H., Tanskanen, A., & Viinamaki, H. (2001). Mood improvement reduces memory complaints in depressed patients. European Archives of Psychiatry and Clinical Neuroscience, 251, 6-11.
2. Austin, M.P., Mitchell, P., & Goodwin, G.M. (2001). Cognitive deficits in depression: Possible implications for functional neuropathology. British Journal of Psychiatry, 178, 200-206.
3. Bates, M.E., Bowden, S.C., & Barry, D. (2002). Neurocognitive impairment associated with alcohol use disorders: Implications for treatment. Experimental and Clinical Psychopharmacology, 10, 193-212.
4. Brekke, J.S., Raine, A., Ansel, M., Lencz, T., & Bird, L. (1997). Neuropsychological and psychophysiological correlates of psychosocial functioning in schizophrenia. Schizophrenia Bulletin, 23, 19-28.
5. Brickenkamp, R. (1978). Test d2. Handanweisung [Test d2. Manual]. Göttingen, Germany: Hogrefe.
6. Chen, E.Y., Kwok, C.L., Chen, R.Y., & Kwong, P.P. (2001). Insight changes in acute psychotic episodes: a prospective study of Hong Kong Chinese patients. Journal of Nervous and Mental Disease, 189, 24-30.
7. Cuesta, M.J., Peralta, V., & Juan, J.A. (1996). Abnormal subjective experiences in schizophrenia: Its relationships with neuropsychological disturbances and frontal signs. European Archives of Psychiatry and Clinical Neuroscience, 246, 101-105.
8. Donohoe, G., Owens, N., O'Donnell, C., Burke, T., Moore, L., Tobin, A., & O'Callaghan, E. (2001). Predictors of compliance with neuroleptic medication among inpatients with schizophrenia: a discriminant function analysis. European Psychiatry, 16, 293-298.
9. Giovagnoli, A.R., Mascheroni, S., & Avanzini, G. (1997). Self-reporting of everyday memory in patients with epilepsy: relation to neuropsychological, clinical, pathological and treatment factors. Epilepsy Research, 28, 119-128.
10. Gold, J.M., Goldberg, R.W., McNary, S.W., Dixon, L.B., & Lehman, A.F. (2002). Cognitive correlates of job tenure among patients with severe mental illness. American Journal of Psychiatry, 159, 1395-1402.
11. Green, M.F. (1996). What are the functional consequences of neurocognitive deficits in schizophrenia? American Journal of Psychiatry, 153, 321-330.
12. Green, M.F., Kern, R.S., Braff, D.L., & Mintz, J. (2000). Neurocognitive deficits and functional outcome in schizophrenia: Are we measuring the "right stuff"? Schizophrenia Bulletin, 26, 119-136.
13. Harvey, P.D., Serper, M.R., White, L., Parrella, M.J., McGurk, S.R., Moriarty, P.J., Bowie, C., Vadhan, N., Friedman, J., & Davis, K.L. (2001). The convergence of neuropsychological testing and clinical ratings of cognitive impairment in patients with schizophrenia. Comprehensive Psychiatry, 42, 306-313.
14. Helmstaedter, C., Hauff, M., & Elger, C.E. (1998). Ecological validity of list-learning tests and self-reported memory in healthy individuals and those with temporal lobe epilepsy. Journal of Clinical and Experimental Neuropsychology, 20, 365-375.
15. Helmstaedter, C., Lendt, M., & Lux, S. (2001). Verbaler Lernund Merkfähigkeitstest [Verbal Learning and Memory Test]. Göttingen, Germany: Beltz.
16. Heubrock, D. (1992). Der Auditiv-Verbale Lerntest (AVLT) in der klinischen und experimentellen Neuropsychologie. Durchführung, Auswertung und Forschungsergebnisse [The Auditory-Verbal Learning Test (AVLT) in clinical and experimental neuropsychology. Administration, evaluation, and research findings]. Zeitschrift für Differentielle und Diagnostische Psychologie, 3, 161-174.
17. Horner, M.D., Harvey, R.T., & Denier, C.A. (1999). Self-report and objective measures of cognitive deficit in patients entering substance abuse treatment. Psychiatry Research, 86, 155-161.
18. Kopelman, M.D., Stanhope, N., & Guinan, E. (1998). Subjective memory evaluations in patients with focal frontal diencephalic and temporal lobe lesion. Cortex, 34, 191-207.
19. Krausz, M., Moritz, S., Lambert, M., & Naber, D. (2009). Dosage of conventional neuroleptic medication and subjective cognitive functioning in schizophrenia. International Clinical Psychopharmacology, 15, 77-81.
20. Kurtz, M.M., Moberg, P.J., Gur, R.C., & Gur, R.E. (2001). Approaches to cognitive remediation of neuropsychological deficits in schizophrenia: A review and meta-analysis. Neuropsychology Review, 11, 197-210.
21. Lannoo, E., Colardyn, F., Vandekerckhove, T., Deyne, C. de, Soete, G. de, & Jannes, C. (1998). Subjective complaints versus neuropsychological test performance after moderate to severe head injury. Acta Neurochirugica, 140, 245-253.
22. Le Fevre, P.D. (2001). Improving the physical health of patients with schizophrenia: Therapeutic nihilism or realism? Scottish Medical Journal, 46, 11-13.
23. Lezak, M.D. (1995). Neuropsychological assessment. (3rd ed.). Oxford, UK: Oxford University Press.
24. Meehl, P.E. (1997). Credentialed persons, credentialed knowledge. Clinical Psychology: Science and Practice, 4, 91-98.
25. Moore, L.H., van Gorp, W.G., Hinkin, C.H., Stern, M.J., Swales, T., & Satz, P. (1997). Subjective complaints versus actual cognitive deficits in predominantly symptomatic HIV-1 seropositive individuals. Journal of Neuropsychiatry and Clinical Neurosciences, 9, 37-44.
26. Moritz, S., Iverson, G., & Woodward, T.S. (2003). Reliable change indexes for memory performance in schizophrenia as a means to determine drug-induced cognitive decline. Applied Neuropsychology, 10, 115-120.
27. Moritz, S., Kloss, M., Jahn, H., Hand, I., Haasen, C., & Krausz, M. (2002a). Executive functioning in obsessive-compulsive disorder, unipolar depression and schizophrenia. Archives of Clinical Neuropsychology, 17, 477-483.
28. Moritz, S., Krausz, M., Gottwalz, E., Lambert, M., Perro, C., Ganzer, S., & Naber, D. (2000). Cognitive dysfunction at baseline predicts symptomatic one-year outcome in first-episode schizophrenics. Psychopathology, 33, 48-51.
29. Moritz, S., Perro, C., Woodward, T.S., & Krausz, M. (2002b). Subjective cognitive dysfunction in first-episode patients predicts symptomatic outcome: A replication. Psychopathology, 35, 367-368.
30. Moritz, S., Woodward, T.S., PERSIST Study Group, Krausz, M., & Naber, D. (2002c). Relationship between neuroleptic dosage and subjective cognitive dysfunction in schizophrenic patients treated with either conventional or atypical neuroleptic medication. International Clinical Psychopharmacology, 17, 41-44.
31. Newman, S., Klinger, L., Venn, G., Smith, P., Harrison, M., & Treasure, T. (l989). Subjective reports of cognition in relation to assessed cognitive performance following coronary artery bypass surgery. Journal of Psychosomatic Research, 33, 227-233.
32. Nishiyama, K., Sugishita, M., Kurisaki, H., & Sakuta, M. (1998). Reversible memory disturbance and intelligence impairment induced by long-term anticholinergic therapy. Internal Medicine, 37, 514-518.
33. Nixon, S.J. & Phillips, J.A. (1999). Neurocognitive deficits and recovery in chronic alcohol abuse. CNS Spectrums, 4, 95-102.
34. Perez, M. & Godoy, J. (1998). Comparison between a "traditional" memory test and a "behavioral" memory battery in Spanish patients. Journal of Clinical and Experimental Neuropsychology, 20, 496-502.
35. Rammsayer, T.H., Rodewald, S., & Groh, D. (2000). Dopamine-antagonistic, anticholinergic, and GABAergic effects on declarative and procedural memory functions. Brain Research, 9, 61-71.
36. Reitan, R.M. (1992). Trail Making Test. Manual of administration and scoring. Tuscon, AZ: Reitan Neuropsychology Laboratory.
37. Rossell, S.L., Coakes, J., Shapleske, J., Woodruff, P.W.R., & David, A.S. (2003). Insight: Its relationship with cognitive function, brain volume and symptoms in schizophrenia. Psychological Medicine, 33, 111-119.
38. Smith, G.E., Petersen, R.C., Ivnik, R.J., Malec, J.F., & Tangalos, E.G. (1996). Subjective memory complaints, psychological distress, and longitudinal change in objective memogy performance. Psychology and Aging, 11, 272-279.
39. Strome, T.M. (1989). Schizophrenia in the elderly: What nurses need to know. Archives of Psychiatric Nursing, 3, 47-52.
40. Theml, T. & Romero, B. (1991). Selbstbeurteilung von Aufmerksamkeitsdefiziten bei Alzheimer-Kranken mit sehr leichter Demenz. Eine explorative Studie [Self-reported attention deficits in patients with mild dementia of the Alzheimer type. A preliminary study]. Zeitschrift für Neuropsychologie, 12, 151-159.
41. Tonne, U., Hiltunen, A.J., Vikander, B., Engelbrektsson, K., Bergman, H., Bergman, I., Leifman, H., & Borg, S. (1995). Neuropsychological changes during steady-state drug use, withdrawal and abstinence in primary benzodiazepine-dependent patients. Acta Psychiatrica Scandinavica, 91, 299-304.
42. Vadhan, N.P., Serper, M.R., Harvey, P.D., Chou, J.C.-Y., & Cancro, R. (2001). Convergent validity and neuropsychological correlates of the schedule for the assessment of negative symptoms (SANS) attention subscale. Journal of Nervous and Mental Disease, 189, 637-641.
43. van den Bosch, R.J. & Rombouts, R.P. (1998). Causal mechanisms of subjective cognitive dysfunction in schizophrenic and depressed patients. Journal of Nervous and Mental Disease, 186, 364-368.
44. Velligan, D.I., Bow-Thomas, C.C., Mahurin, R.K., Miller, A.L., & Halgunseth, L.C. (2000). Do specific neurocognitive deficits predict specific domains of community function in schizophrenia? Journal of Nervous and Mental Disease, 188, 518-524.
45. von Zerssen, D. & Koeller, D.M. (1976). Paranoid-Depressivitäts Skala (PDS) [Paranoid-Depression Scale]. Göttingen, Germany: Hogrefe.
46. Wagle, A.C., Berrios, G.E., & Ho, L. (1999). The cognitive failures questionnaire in psychiatry. Comprehensive Psychiatry, 40, 478-484.
47. Wilder-Willis, K.E., Shear, P.K., Steffen, J.J., & Borkin, J. (2002). The relationship between cognitive dysfunction and coping abilities in schizophrenia. Schizophrenia Research, 55, 259-267.
48. Wilson, B., Cockburn, J., & Baddeley, A. (1992). Rivermead Behavioural Memory Test. German translation. Bury St. Edmunds, UK: Thames Valley Test Company.
49. World Health Organization. (1993). The ICD-10 classification of mental and behavioural disorders: Primary health care classification. Geneva: WHO.
50. Zimmerman, M. & Mattia, J.I. (1999). Psychiatric diagnosis in clinical practice: is comorbidity being missed? Comprehensive Psychiatry, 40, 182-191.
51. Zimmermann, P. & Fimm, B. (1994). Testbatterie zur Aufmerksamkeitsprüfung (TAP) [Test Battery for the Assessment of Attentional Dysfunction]. Herzogenrath, Germany: Psytest.
52. Zimmermann, P., Messner, C., Poser, U., & Sedelmeier, P. (1991). Ein Fragebogen erlebter Defizite der Aufmerksamkeit (FEDA) [a questionnaire measuring self-experienced deficits of attention]. Freiburg, Germany: Psychologisches Institut der Universität Freiburg.